Search - tctmd.com

Displaying 341 - 360 of 2790

Sort: Relevancy | Date

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

News Conference News

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

Yael L. Maxwell

March 26, 2024

Peer Coaching May Help With BP Control in Rural Black Populations

News Daily News

Peer Coaching May Help With BP Control in Rural Black Populations

March 22, 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

March 15, 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

March 14, 2024

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

March 07, 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Plastic Debris Found in Carotid Plaque Linked to More Adverse CV Events

News Daily News

Plastic Debris Found in Carotid Plaque Linked to More Adverse CV Events

March 06, 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Semaglutide Winning Streak Continues in CKD With FLOW

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

March 06, 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

March 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

March 01, 2024

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

News Daily News

More Complications in Pregnancy Equals Higher Risk of ASCVD Mortality

February 28, 2024

Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study

News Daily News

Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study

February 28, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

News Daily News

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

February 26, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.